| Literature DB >> 16428158 |
Tohru Tanigawa1, Meiho Nakayama, Tomohiko Nakamura, Shigeru Inafuku.
Abstract
We used trafermin (recombinant human basic fibroblast growth factor) to treat a skin ulcer (diameter, 1 cm; depth, 2 mm) that developed after an extremely deep auricular laceration was sutured. Excellent results were obtained after use of trafermin for 2 weeks. To our knowledge, we report the first clinical use of trafermin in a patient with a skin ulcer resulting from auricular trauma. Trafermin may promise to be an effective treatment for skin ulcers.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16428158 DOI: 10.1080/09546630500375817
Source DB: PubMed Journal: J Dermatolog Treat ISSN: 0954-6634 Impact factor: 3.359